复星医药:累计耗资1910.011万元回购注销89.714万股A股限制性股票

公司公告
27 May

复星医药公告,因部分激励对象离职及2024年度业绩考核未达标,公司回购注销合计89.714万股A股限制性股票,回购总价为1910.011万元。本次注销完成后,公司总股本将从267132.647万股减少至267042.933万股,控股股东持股比例略有上升。

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10